BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 36871413)

  • 81. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy.
    Matsuo M; Shirakawa T; Awano H; Nishio H
    Clin Chim Acta; 2018 Nov; 486():110-114. PubMed ID: 30053403
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A microtubule-connexin-43 regulatory link suppresses arrhythmias and cardiac fibrosis in Duchenne muscular dystrophy mice.
    Himelman E; Nouet J; Lillo MA; Chong A; Zhou D; Wehrens XHT; Rodney GG; Xie LH; Shirokova N; Contreras JE; Fraidenraich D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H983-H995. PubMed ID: 36206047
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy.
    Benny Klimek ME; Vila MC; Edwards K; Boehler J; Novak J; Zhang A; Van der Meulen J; Tatum K; Quinn J; Fiorillo A; Burki U; Straub V; Lu QL; Hathout Y; van Den Anker J; Partridge TA; Morales M; Hoffman E; Nagaraju K
    J Neuromuscul Dis; 2021; 8(s2):S369-S381. PubMed ID: 34569970
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
    Roger AL; Biswas DD; Huston ML; Le D; Bailey AM; Pucci LA; Shi Y; Robinson-Hamm J; Gersbach CA; ElMallah MK
    Respir Physiol Neurobiol; 2024 Aug; 326():104282. PubMed ID: 38782084
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Current Translational Research and Murine Models For Duchenne Muscular Dystrophy.
    Rodrigues M; Echigoya Y; Fukada SI; Yokota T
    J Neuromuscul Dis; 2016 Mar; 3(1):29-48. PubMed ID: 27854202
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
    Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Titin fragment in urine: A noninvasive biomarker of muscle degradation.
    Matsuo M; Awano H; Maruyama N; Nishio H
    Adv Clin Chem; 2019; 90():1-23. PubMed ID: 31122607
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.
    Walmsley GL; Arechavala-Gomeza V; Fernandez-Fuente M; Burke MM; Nagel N; Holder A; Stanley R; Chandler K; Marks SL; Muntoni F; Shelton GD; Piercy RJ
    PLoS One; 2010 Jan; 5(1):e8647. PubMed ID: 20072625
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
    Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
    Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.
    Lu-Nguyen NB; Jarmin SA; Saleh AF; Popplewell L; Gait MJ; Dickson G
    Mol Ther; 2015 Aug; 23(8):1341-1348. PubMed ID: 25959011
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
    Siemionow M; Brodowska S; Langa P; Zalants K; Kozlowska K; Grau-Kazmierczak W; Heydemann A
    Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):20. PubMed ID: 35978142
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development.
    Vulin A; Wein N; Simmons TR; Rutherford AM; Findlay AR; Yurkoski JA; Kaminoh Y; Flanigan KM
    Neuromuscul Disord; 2015 Nov; 25(11):827-34. PubMed ID: 26365037
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cardiovascular phenotype of the
    Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Connexin-43 reduction prevents muscle defects in a mouse model of manifesting Duchenne muscular dystrophy female carriers.
    Nouet J; Himelman E; Lahey KC; Zhao Q; Fraidenraich D
    Sci Rep; 2020 Mar; 10(1):5683. PubMed ID: 32231219
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Motor axonopathies in a mouse model of Duchenne muscular dystrophy.
    Dhindsa JS; McCall AL; Strickland LM; Fusco AF; Kahn AF; ElMallah MK
    Sci Rep; 2020 Jun; 10(1):8967. PubMed ID: 32488044
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Mikheeva IB; Sharapov MG; Belosludtsev KN
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165674. PubMed ID: 31926263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.